DGX(DGX)
DGX
Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data
Next report
Oct 22 2026in 15 days
EPS estimate
$2.87
Revenue estimate
$3.05B
EPS beats
12 of last 12
EPS surprise
Each report against the estimate that stood when it landed.
Oct 24 2023Jul 23 2026
| Reported | EPS est | EPS actual | Surprise | Revenue est | Revenue actual | Surprise |
|---|---|---|---|---|---|---|
| Jul 23 2026 | $2.82 | $3.12 | +10.6% | $2.97B | $3.04B | +2.4% |
| Apr 21 2026 | $2.37 | $2.50 | +5.5% | $2.83B | $2.90B | +2.3% |
| Feb 10 2026 | $2.36 | $2.42 | +2.5% | $2.75B | $2.81B | +1.9% |
| Oct 21 2025 | $2.50 | $2.60 | +4.0% | $2.74B | $2.82B | +2.9% |
| Jul 22 2025 | $2.57 | $2.62 | +1.9% | $2.73B | $2.76B | +1.3% |
| Apr 22 2025 | $2.15 | $2.21 | +2.8% | $2.63B | $2.65B | +0.8% |
| Jan 30 2025 | $2.19 | $2.23 | +1.8% | $2.58B | $2.62B | +1.6% |
| Oct 22 2024 | $2.26 | $2.30 | +1.8% | $2.43B | $2.49B | +2.3% |
| Jul 23 2024 | $2.34 | $2.35 | +0.4% | $2.39B | $2.40B | +0.3% |
| Apr 23 2024 | $1.86 | $2.04 | +9.7% | $2.29B | $2.37B | +3.5% |
| Feb 1 2024 | $2.11 | $2.15 | +1.9% | $2.25B | $2.29B | +1.5% |
| Oct 24 2023 | $2.19 | $2.22 | +1.4% | $2.27B | $2.29B | +1.0% |
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+4.64%
EPS+7.73%
FY2028
Rev+4.29%
EPS+8.60%
FY2029
Rev+5.49%
EPS+12.86%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $12.01B | $12.56B | $13.10B | $13.82B | $11.56B |
| Low | $11.98B | $12.47B | $12.86B | $13.67B | $11.43B |
| High | $12.10B | $12.77B | $13.35B | $14.01B | $11.72B |
| EBITDA Avg | $2.50B | $2.59B | $2.74B | $3.05B | $3.04B |
| Low | $2.49B | $2.59B | $2.64B | $3.02B | $3.01B |
| High | $2.50B | $2.67B | $2.94B | $3.09B | $3.08B |
| EBIT Avg | $1.94B | $2.04B | $2.18B | $2.49B | $2.50B |
| Low | $1.93B | $2.03B | $2.08B | $2.46B | $2.46B |
| High | $1.95B | $2.12B | $2.39B | $2.53B | $2.54B |
| Net Income Avg | $1.27B | $1.34B | $1.44B | $1.67B | $1.67B |
| Low | $1.26B | $1.34B | $1.37B | $1.65B | $1.65B |
| High | $1.27B | $1.39B | $1.60B | $1.70B | $1.70B |
| EPS Avg | $11.19 | $12.06 | $13.10 | $14.78 | $14.82 |
| Low | $11.16 | $11.82 | $12.11 | $14.57 | $14.61 |
| High | $11.23 | $12.34 | $14.13 | $15.04 | $15.09 |
| Analysts (Rev / EPS) | 13 / 11 | 13 / 11 | 11 / 8 | 5 / 5 | 5 / 5 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $3.01B | $3.03B | $3.18B | $3.19B | $3.15B | $3.18B | $3.30B | $3.31B |
| Low | $2.98B | $2.97B | $3.11B | $3.13B | $3.09B | $3.11B | $3.23B | $3.24B |
| High | $3.08B | $3.11B | $3.26B | $3.28B | $3.23B | $3.26B | $3.39B | $3.40B |
| EBITDA Avg | $519M | $537M | $600M | $599M | $578M | $600M | $639M | $634M |
| Low | $513M | $526M | $587M | $586M | $565M | $588M | $625M | $621M |
| High | $525M | $552M | $617M | $615M | $593M | $616M | $656M | $651M |
| EBIT Avg | $472M | $486M | $545M | $540M | $515M | $534M | $569M | $560M |
| Low | $466M | $475M | $532M | $527M | $502M | $521M | $555M | $547M |
| High | $478M | $501M | $562M | $556M | $530M | $550M | $586M | $577M |
| Net Income Avg | $300M | $311M | $354M | $350M | $332M | $346M | $372M | $365M |
| Low | $296M | $302M | $345M | $341M | $323M | $336M | $361M | $355M |
| High | $305M | $321M | $366M | $362M | $343M | $358M | $384M | $378M |
| EPS Avg | $2.68 | $2.78 | $3.16 | $3.13 | $2.96 | $3.09 | $3.32 | $3.26 |
| Low | $2.64 | $2.70 | $3.08 | $3.04 | $2.88 | $3.00 | $3.23 | $3.17 |
| High | $2.72 | $2.87 | $3.27 | $3.23 | $3.06 | $3.19 | $3.43 | $3.37 |
| Analysts (Rev / EPS) | 9 / 10 | 7 / 8 | 4 / 8 | 4 / 8 | 7 / 8 | 7 / 9 | 3 / 9 | 4 / 9 |
AI Earnings SummaryQ2 2026
Checking for summary...
Explore More
Healthcare Stocks
More Healthcare stocks
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers
